Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating The Effect of Ramipril On Urinary Protein Excretion In Maintenance Renal Transplant Patients Converted To Sirolimus

NCT00502242 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00502242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00502242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating The Effect of Ramipril On Urinary Protein Excretion In Maintenance Renal Transplant Patients Converted To Sirolimus
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2007
Completion date
September 30, 2013
Enrollment
229 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant